See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Evolv Technologies Holdings, Inc. (EVLV) - free report >>
Verona Pharma PLC American Depositary Share (VRNA) - free report >>
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Evolv Technologies Holdings, Inc. (EVLV) - free report >>
Verona Pharma PLC American Depositary Share (VRNA) - free report >>
Image: Bigstock
Best Momentum Stock to Buy for July 7th
Here are two stocks with buy rank and strong momentum characteristics for investors to consider today, July 7th:
Verona Pharma (VRNA - Free Report) : This company which is focused on developing and commercializing innovative therapeutics for the treatment of patients burdened with chronic respiratory diseases with significant unmet medical needs, has a Zacks Rank #1(Strong Buy), and witnessed the Zacks Consensus Estimate for its current year earnings increasing 37.5% over the last 60 days.
Verona Pharma PLC American Depositary Share Price and Consensus
Verona Pharma PLC American Depositary Share price-consensus-chart | Verona Pharma PLC American Depositary Share Quote
Verona Pharma’s shares gained 69% over the last three month compared with the S&P 500’s gain of 26%. The company possesses a Momentum Score of A.
Verona Pharma PLC American Depositary Share Price
Verona Pharma PLC American Depositary Share price | Verona Pharma PLC American Depositary Share Quote
Evolv Technologies (EVLV - Free Report) : This company which offer an array of AI touchless screening technologies for weapons detection, identity verification and health-related threats through Evolv Cortex AI(TM) software platform, has a Zacks Rank #1, and witnessed the Zacks Consensus Estimate for its current year earnings increasing 23.3% over the last 60 days.
Evolv Technologies Holdings, Inc. Price and Consensus
Evolv Technologies Holdings, Inc. price-consensus-chart | Evolv Technologies Holdings, Inc. Quote
Evolv Technologies' shares gained 100.7% over the last three month compared with the S&P 500’s gain of 25.9%. The company possesses a Momentum Score of B.
Evolv Technologies Holdings, Inc. Price
Evolv Technologies Holdings, Inc. price | Evolv Technologies Holdings, Inc. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.